Results: Our study suggests that PREX2 and AHCYL1 both promote NSCLC cell growth and proves that AHCYL1 enhances the GEF activity of PREX2 by alleviating the mutual inhibition between PREX2 and PTEN. This evidence concerns the gene PTEN and non-small cell lung carcinoma.